Ohio’s attorney general filed a lawsuit against Purdue Pharma, Endo Health Solutions, Teva, Johnson & Johnson and Allergan this week, alleging they contributed to the opioid epidemic through fraudulent advertising.…
The Supreme Court’s ruling this week on a patent dispute over printer toner cartridges could have wider effects on the pharmaceutical industry, international sales and product reimportation. Source: Drug Industry…
The FDA sent a warning to a drug manufacturing facility in Irvine, Calif., for failure to resolve quality issues dating back to 2013. Source: Drug Industry Daily
The FDA approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit hyperactivity disorder in pediatric and adult patients, including multiple strengths manufactured by Apotex, Teva, Aurobindo Pharma and…
The European Medicines Agency announced a three-year, 16-point action plan to boost small- and medium-sized pharmaceutical companies. Source: Drug Industry Daily
The HHS inspector general’s office is estimating that taxpayers overpaid for the EpiPen by as much as $1.27 billion between 2006 and 2016. Source: Drug Industry Daily
The European Medicines Agency says marketing authorization holders must be based in the European Economic Area post-Brexit — and UK-based companies will likely need to transfer marketing authorizations to new…
A European Medicines Agency pharmacovigilance panel has issued new labeling recommendations to sponsors of certain approved drug products. Source: Drug Industry Daily
The European Medicines Agency named five treatments as eligible for its priority medicines program, bringing the total to 25. Source: Drug Industry Daily
Amgen is suing the FDA, requesting that its Sensipar medication be granted six additional months of pediatric market exclusivity after it completed three of four pediatric clinical trials requested by…